About COVID-RED

COVID-RED is a project that is part of the EU Innovative Medicines Initivative and will evaluate the use and performance of a CE-marked device (wearable), which uses sensors to measure breathing rate, pulse rate, skin temperature, and heart rate variability for the purpose of early detection and monitoring of COVID-19 in general and high-risk populations. At the same time, a mobile application will be used to track participant-reported symptoms.
READ MORE >>

NEWS

LEES MEER
Pilot studie COVID-RED
Apr
09
2021
Lees meer >
LEES MEER
COVID-RED in het nieuws
Apr
01
2021
Lees meer >

Twitter

Als u nog twijfelt over deelname of nog overige vragen heeft, kijk dan eens bij https://www.covid-red.eu/veelgestelde-vragen/. Staat uw vraag daar niet tussen? Dan kunt u contact opnemen met de helpdesk en dan helpen wij u verder. https://www.covid-red.eu/contact/ #coronavirus #ClinicalResearch

#mijlpaal 15.000 deelnemers hebben zich aangemeld voor het COVID-RED #onderzoek naar #corona, opgezet door o.a. @UMCUtrecht @RocheDiaNL @JuliusClinical @sanquin en @AvaWomen! Nog 5.000 te gaan om ons einddoel te halen. Wij willen alle deelnemers bedanken voor hun inzet. #bedankt

Instagram

COVID-RED

Uw hulp in de strijd tegen corona

The COVID-RED consortium

The COVID-RED consortium brings together nine organisations from four countries with the aim to deliver a large body of information on COVID-19 monitoring that can be used to develop additional diagnostics and therapeutics in addition to validating remote vital signs and self-reported symptoms monitoring systems.

OUR CONSORTIUM
»

The COVID-RED project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101005177. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA.